A Switch-Over, Open-Label Study of the Safety, Pharmacok

Project: Research project

Description

A Switch-Over, Open-Label Study of the Safety, Pharmacokinetics, and Efficacy of HPN-100, Followed by Long-Term Treatment with HPN-100, in Pediatric Subjects under 6 Years of Age with Urea Cycle Disorders (UCDs)
StatusFinished
Effective start/end date4/7/118/1/13

Funding

  • Hyperion Therapeutics

Fingerprint

Inborn Urea Cycle Disorder
Pharmacokinetics
Pediatrics
Safety
glycerol phenylbutyrate